[1]
J. Julaeha, U. Athiyah, J. P. Ayuningtyas, V. Yuliana, and A. Hermansyah, “Metabolic Syndrome Risk Associated with Atypical Antipsychotic Medication: A Case Report”, JDDT, vol. 11, no. 1, pp. 77-79, Jan. 2021.